Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Podrid

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
Pharmacoeconomics|November 4, 1992
Pharmacoeconomic considerations in antiarrhythmic therapyP J Podrid, R J Arnold, D J Kaniecki
The American Journal of Cardiology|August 29, 1986
Safety and efficacy of encainide for malignant ventricular arrhythmiasT Tordjman, P J Podrid, E Raeder, et al.
Circulation|February 1, 1980
Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexesP J Podrid, A Lyakishev, B Lown, et al.
Journal of the American College of Cardiology|November 1, 1989
Congestive heart failure induced by six of the newer antiarrhythmic drugsS Ravid, P J Podrid, S Lampert, et al.
The American Journal of Cardiology|February 1, 1988
Clinical predictors of arrhythmia worsening by antiarrhythmic drugsW Slater, S Lampert, P J Podrid, et al.
American Heart Journal|July 1, 1985
Aggravation of arrhythmia induced with antiarrhythmic drugs during electrophysiologic testingR F Poser, P J Podrid, F Lombardi, et al.
Circulation|February 1, 1986
Use of short-term drug testing as part of a systematic approach for evaluation of antiarrhythmic drugsP J Podrid, B Lown, T B Graboys, et al.
The American Journal of Cardiology|September 1, 1982
Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugsT B Graboys, B Lown, P J Podrid, et al.
The American Journal of Cardiology|October 16, 1987
Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmiasM J Hession, S Lampert, P J Podrid, et al.
Circulation|April 1, 1987
Exercise stress testing for exposure of arrhythmiasP J Podrid, T B Graboys, S Lampert, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Pharmacoeconomics|November 4, 1992
Pharmacoeconomic considerations in antiarrhythmic therapyP J Podrid, R J Arnold, D J Kaniecki
The American Journal of Cardiology|August 29, 1986
Safety and efficacy of encainide for malignant ventricular arrhythmiasT Tordjman, P J Podrid, E Raeder, et al.
Circulation|February 1, 1980
Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexesP J Podrid, A Lyakishev, B Lown, et al.
Journal of the American College of Cardiology|November 1, 1989
Congestive heart failure induced by six of the newer antiarrhythmic drugsS Ravid, P J Podrid, S Lampert, et al.
The American Journal of Cardiology|February 1, 1988
Clinical predictors of arrhythmia worsening by antiarrhythmic drugsW Slater, S Lampert, P J Podrid, et al.
American Heart Journal|July 1, 1985
Aggravation of arrhythmia induced with antiarrhythmic drugs during electrophysiologic testingR F Poser, P J Podrid, F Lombardi, et al.
Circulation|February 1, 1986
Use of short-term drug testing as part of a systematic approach for evaluation of antiarrhythmic drugsP J Podrid, B Lown, T B Graboys, et al.
The American Journal of Cardiology|September 1, 1982
Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugsT B Graboys, B Lown, P J Podrid, et al.
The American Journal of Cardiology|October 16, 1987
Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmiasM J Hession, S Lampert, P J Podrid, et al.
Circulation|April 1, 1987
Exercise stress testing for exposure of arrhythmiasP J Podrid, T B Graboys, S Lampert, et al.
Pageof 11